ACT Genomics is a pioneer in personalized medicine, utilizing cutting-edge genomic testing to create tailored treatment plans for cancer patients. Founded in 2014 by a group of scientists, ACT Genomics is deeply rooted in Asia and committed to constant innovation. Their mission is to make advanced genomic testing accessible to everyone, empowering patients and doctors to stay ahead of cancer.
Challenge
Despite their innovative approach, ACT Genomics faced challenges in effectively communicating their unique value proposition. The complexities of genomic testing and the emotional nature of cancer diagnosis demanded a delicate balance of scientific accuracy and compassionate communication. They needed to distinguish themselves in a competitive market while building trust with patients and the medical community.
Approach
Level™ partnered with ACT Genomics to develop a brand strategy and digital presence that conveyed warmth, trust, and scientific rigor. Our approach focused on creating a clear, compassionate brand narrative that emphasized patient-centricity and accessibility. We crafted a modern visual identity that reflected these values, incorporating subtle references to genetics and personalized care. The redesigned website prioritized patient education and support, clearly explaining the benefits of personalized medicine and ACT Genomics' unique approach.
By clicking “Accept”, you agree to the storing of cookies on your device to analyze and enhance site usage. View our Privacy Policy for more information.
